Clever Leaves Holdings Inc. (CLVR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -15.59 Million USD | 46.52% |
| 2022 | -29.16 Million USD | 24.65% |
| 2021 | -38.69 Million USD | -44.15% |
| 2020 | -26.84 Million USD | 26.53% |
| 2019 | -36.54 Million USD | -575.67% |
| 2018 | -5.4 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | -3.17 Million USD | 23.12% |
| 2023 Q1 | -4.13 Million USD | 27.15% |
| 2023 Q3 | -3.37 Million USD | -6.36% |
| 2023 Q4 | -4.91 Million USD | -45.45% |
| 2023 FY | -15.59 Million USD | 46.52% |
| 2022 Q4 | -5.66 Million USD | 76.69% |
| 2022 Q3 | -24.32 Million USD | -354.82% |
| 2022 FY | -29.16 Million USD | 24.65% |
| 2022 Q2 | -5.34 Million USD | 32.18% |
| 2022 Q1 | -7.88 Million USD | 73.85% |
| 2021 FY | -38.69 Million USD | -44.15% |
| 2021 Q4 | -30.15 Million USD | -211.36% |
| 2021 Q3 | -9.68 Million USD | -0.84% |
| 2021 Q2 | -9.6 Million USD | -23.62% |
| 2021 Q1 | -7.76 Million USD | -6.15% |
| 2020 Q4 | -7.31 Million USD | -55.34% |
| 2020 Q3 | -4.71 Million USD | 35.69% |
| 2020 Q2 | -7.32 Million USD | 20.15% |
| 2020 Q1 | -9.17 Million USD | 47.05% |
| 2020 FY | -26.84 Million USD | 26.53% |
| 2019 Q1 | -4.42 Million USD | 0.0% |
| 2019 FY | -36.54 Million USD | -575.67% |
| 2019 Q3 | -8.92 Million USD | -69.81% |
| 2019 Q4 | -17.32 Million USD | -94.21% |
| 2019 Q2 | -5.25 Million USD | -18.82% |
| 2018 FY | -5.4 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Bright Green Corporation | -8.89 Million USD | -75.383% |
| BioQuest Corp. | -89.76 USD | -17372894.652% |
| Eagle Pharmaceuticals, Inc. | 53.45 Million USD | 129.173% |
| Guardion Health Sciences, Inc. | -4.33 Million USD | -259.614% |
| GSRX Industries Inc. | - USD | Infinity% |
| High Sierra Technologies, Inc. | -238.36 Thousand USD | -6442.095% |
| Instadose Pharma Corp. | - USD | Infinity% |